Taking low dose aspirin does not protect older women against cognitive decline, data from the Women’s Health Study has found.
Jae Hee Kang and colleagues at Brigham and Women’s Hospital in Boston, Massachusetts identified 6,377 women aged 65 years or more, who were taking part in the Women’s health study.
Over a period of nearly 10 years, one group took low dose aspirin (100 mg on alternate days) and the second group took a placebo pill.
After 5.6 years of treatment, cognitive performance in the aspirin group was similar to that shown in the placebo group.
The team conclude: “Other methods for preserving cognitive function in older people need to be investigated.”
Follow us on
